Open Label Extension of TUDCA-ALS Study

NCT05753852 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

184

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Tauroursodeoxycholic Acid

Sponsor

Humanitas Mirasole SpA

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]